Trial intelligence / Profile preview

Intrathecal Nalbuphine vs Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries

NCT07294352Completed

Sponsor
CMH Lahore Medical College and Institute of Dentistry
Start
Jan 2026
Primary completion
Jul 2026
Modality
Orthosteric Ligands
Countries
1
01

Overview

Trial of nalbuphine and tramadol (2 arms), sponsored by CMH Lahore Medical College and Institute of Dentistry. Primary endpoint: Duration of spinal anesthesia. Started Jan 2026; status: completed.

02

Drugs

nalbuphinetramadol

Beyond the preview

Go deeper on NCT07294352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07294352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call